跳至主要内容
临床试验/EUCTR2018-002606-31-DE
EUCTR2018-002606-31-DE进行中(未招募)1 期

Sublingual versus intravenous Fentanyl in patients with acute trauma - a randomized, double-blind, double-dummy study to demonstrate non-inferiorityTraumaPACT

Ruprecht-Karls-University Heidelberg, Medical Faculty represented by Universitätsklinikum Heidelberg and its Commercial0 个研究点目标入组 340 人开始时间: 2019年1月30日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
340

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Age 18-65 years
  • - isolated or combined, non-head trauma
  • - Intravenous access indicated
  • - Glasgow Coma Scale(GCS) score (aggregate of verbal, eye, and motor response scores) of 15 (no disturbance of consciousness)
  • - Stable circulation (blood pressure, pulse) at the discretion of the investigator
  • - Oxygen saturation of at least 95%
  • - Numeric pain rating scale (NRS, 5-10) = 5
  • - Ability of subject to understand character and individual consequences of the clinical trial
  • - Patient (deferred) consent to treatment
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 340
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Pre-treatment with potent opioid-analgesics within 30 days prior to acute trauma
  • - (obvious) pregnancy or lactation
  • - Nasopharyngeal injuries
  • - Obstructive lung disease
  • - Foreseeable indication for endotracheal intubation
  • - Nausea or vomiting expected
  • - History of hypersensitivity to the investigational medicinal product or to any drug with similar chemical structure or to any excipient present in the pharmaceutical form of the investigational medicinal product
  • - legally incapacitated

研究者

发起方
Ruprecht-Karls-University Heidelberg, Medical Faculty represented by Universitätsklinikum Heidelberg and its Commercial

相似试验